Hellman Jordan Management CO Inc Regeneron Pharmaceuticals, Inc. Transaction History

Hellman Jordan Management CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Dec 20, 2019	SELL	$273.46 - $318.39 $5.47 Million - $6.37 Million	-20,000 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$299.6 - $414.82 $5.99 Million - $8.3 Million	20,000 New	20,000 $6.26 Million
Q1 2019 Jun 11, 2019	SELL	$372.08 - $439.57 $3.72 Million - $4.4 Million	-10,000 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $8.4 Million - $10.1 Million	-25,000 Reduced 71.43%	10,000 $3.74 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $5.27 Million - $6.13 Million	-15,000 Reduced 30.0%	35,000 $14.1 Million
Q2 2018 Aug 21, 2018	BUY	$284.6 - $344.99 $14.2 Million - $17.2 Million	50,000 New	50,000 $17.2 Million

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

Stay updated on Hellman Jordan Management CO Inc with notifications on news.